Stallergenes Greer
Silvia Scurati has a background in medical biotechnology and pathophysiology of aging. Currently holding various titles at STALLERGENES GREER, Silvia oversees the launch and management of a respiratory allergy treatment product. Silvia collaborates with cross-functional teams and key opinion leaders to ensure successful product marketing. Prior to this, Silvia conducted research on autoimmune diseases at Istituto Auxologico Italiano.
This person is not in any offices
Stallergenes Greer
1 followers
Stallergenes Greer is a global biopharmaceutical company specializing in the diagnosis and treatment of respiratory allergies through the development and commercialization of Allergy Immunotherapy products and services.